#neurology-referral

#neurology-referral

Lewy body dementia (LBD) is the second-most-common neurodegenerative cause of dementia, after Alzheimer's Disease. But it's the most-common cause that doesn't receive sufficient attention.

When Lorraine Kelly Donnelly felt a cramp in her left hand at the start of 2025, she didn't think anything of it. But when a week later the pain was still there, she made an appointment to see her GP.

The condition, called recessive RNU2-2-related neurodevelopmental disorder, is associated with seizures and severe developmental delay in children less than a year-old, in areas such as speech and walking.

According to University of Michigan neuroscientists, not only can their AI vision language model diagnose neurological disorders from MRI scans with high performance accuracy, but it also has foundation model capabilities, making it a flexible, general-purpose solution that can be tailored for a wide variety of medical imaging. "These results demonstrate that Prima has foundation model properties, and reported performance will continue to improve with additional health system training data and larger compute budgets," wrote the study's authors in the preprint.

A groundbreaking study found that adults who sit for 10 or more hours daily face a significantly higher risk of dementia compared to those who sit less. The research, which tracked over 50,000 adults using wearable devices, revealed that the risk increases dramatically after crossing that 10-hour threshold.

The human brain is complex. Artificial intelligence (AI) machine learning and medical imaging data are accelerating breakthroughs in brain health, especially in medical diagnostics. A peer-reviewed study published today in Nature Neuroscience unveils an AI foundation model called BrainIAC (Brain Imaging Adaptive Core) that is capable of predicting brain age, dementia, time-to-stroke, and brain cancer from brain magnetic resonance imaging (MRI).

We've always said that SuperAgers show that the aging brain can be biologically active, adaptable, flexible, but we didn't know why. This is biological proof that their brains are more plastic, and a real discovery that shows that neurogenesis of young neurons in the hippocampus may be a contributing factor.

Most people will forget a name, misplace their phone, or lose track of a conversation at some point. Usually, those moments pass without much thought. But for many adults, especially as they age, small lapses can trigger a much deeper fear: Is this the beginning of cognitive decline? As a neurologist, I hear this concern often. And as a researcher, I have learned something important: Worry about cognition and cognitive disease are not the same thing.

If you're going to prioritize one thing for your brain health, make it this: regular aerobic exercise. Multiple large-scale studies show that aerobic exercise doesn't just keep your heart healthy-it directly impacts your brain structure. One year of aerobic exercise in older adults led to significantly larger hippocampal volumes and better spatial memory. Other trials documented that exercise actually slows age-related gray matter volume loss.

Haavik was surprised to hear this because the scientific data do not suggest an unequivocal link between low levels of the neurotransmitter dopamine and ADHD. But the idea that low dopamine is a direct cause of ADHD is a common misconception, one that's amplified on social media and even in popular books about the condition. The reality, Haavik and other researchers say, is that the causes of ADHD are more diverse and nuanced than a simple deficit in one chemical cue in the brain.

Sometimes it's a fall that brings a broken hip and a loss of mobility. Or memory problems that bubble into danger. Or the death of the partner who was relied upon for care.The need to move to a nursing home, assisted living facility or another type of care setting often comes suddenly, setting off an abrupt, daunting search. It's likely something no one ever wanted, but knowing what to look for and what to ask can make a big difference.

Summer passed Valerie Zeko by when she was 27, as she vegged out on the couch watching TV instead of seeing friends or exploring the overcast beach near her house. She later learned that period was her first episode of depression. I felt like the fog was in my head as well as outside, said Zeko, now 57, describing the mood disorder that would squelch her happiness, motivation and self-esteem for 28 years until she finally found effective treatment.

Anyone living with schizophrenia understands the true limitations of current treatment options. Antipsychotics remain the single leading treatment for the disorder, and they are riddled with undesirable side effects. Weight gain, tardive dyskinesia, and excessive drowsiness are a few. Much research is devoted to expanding the range of medication options, and few academics have pursued other avenues. However, there is a possibility that treatment for schizophrenia can be approached through cellular methods if long-term research validates early signs of hope.

Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is a rare genetic disorder primarily affecting boys, caused by a deficiency in the enzyme needed to break down sugar molecules. This harmful buildup in cells and tissues impacts multiple body systems, causing frequent infections, organ enlargement and developmental disabilities. Management involves supportive care and enzyme replacement therapy, as there is currently no cure,

When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life. But, ironically, that life-saving rush of blood can also trigger a second wave of damage - killing brain cells, fueling inflammation and increasing the odds of long-term disability. Now, in a study published in the journal Neurotherapeutics, Northwestern University scientists have developed an injectable regenerative nanomaterial that helps protect the brain during this vulnerable window.

To make their discovery, researchers examined donated eye tissue from more than 100 people who had died with Alzheimer's, mild cognitive impairment or no signs of dementia. They were looking specifically for C. pneumoniae, because previous research has already linked it to Alzheimer's. The bacteria has also been detected in brain tissue from patients who died with the condition, sometimes found close to the sticky amyloid plaques and tangles believed to drive memory loss and confusion.

But questions remain about the accuracy and uncertainty of these tests, and experts caution that the assays aren't ready for prime time. While the results here are encouraging, they are not yet at the level of having significant clinical benefit for individual patients, says Corey Bolton, a clinical neuropsychologist and an assistant professor of medicine at Vanderbilt University Medical Center, who was not involved in the new study.

They then used emerging mathematical methods to isolate signals originating from nine brain regions previously implicated in mediating consciousness and examined connections between pairs of these regions. Among them were the parietal cortex, which is at the top of the brain about halfway between the forehead and the back of the skull; the occipital cortex, at the back of the head; and several small, deeper structures, such as one called the thalamus.